ACRS..Trading HEAVILY under Cash and with lotsof upcoming news :
ACRS = Market Cap $43 M / Cash $115 M or untill end 2021 / 2 Marketed Products / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Prodcuts which means HUGE upfront payments for the company in short term (more infos below)= CHEAPEST Biotech you can get at this time could triple very quickly
Aclaris Therapeutics (ACRS)
Market Cap: $43 M Cash: $115 M or enough untill end 2021 Price 1.08
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.